Visioneering Technologies this week priced its A$33.3 million initial public offering on the Australian Securities Exchange.
The U.S.-based contact lens maker said it’s offering 79.4 million shares of its Class A common stock priced at ¢42 apiece. The company plans to use the net proceeds from the IPO to provide capital as VTI broadens the U.S. launch of its NaturalVue Multifocal daily disposable contact lenses for adults with presbyopia and children with myopia.
[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]